Formation of neutralizing antibodies during intranasal synthetic salmon calcitonin treatment of postmenopausal osteoporosis
- 1 February 1991
- journal article
- Published by Springer Nature in Osteoporosis International
- Vol. 1 (2) , 72-75
- https://doi.org/10.1007/bf01880446
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- Effect of salcatonin given intranasally on early postmenopausal bone loss.BMJ, 1989
- Estimated long-term effect of calcitonin treatment in acute osteoporotic spine fracturesCalcified Tissue International, 1989
- Bone turnover in postmenopausal osteoporosis. Effect of calcitonin treatment.Journal of Clinical Investigation, 1988
- 1-YEAR CONTROLLED RANDOMISED TRIAL OF PREVENTION OF EARLY POSTMENOPAUSAL BONE LOSS BY INTRANASAL CALCITONINThe Lancet, 1987
- Effects of salmon calcitonin in postmenopausal osteoporosis: A controlled double-blind clinical studyCalcified Tissue International, 1986
- Treatment of osteoporosis with calcitonin, with and without growth hormoneMetabolism, 1985
- Response of Paget’s disease to human calcitonin in patients resistant to porcine calcitoninJournal of Endocrinological Investigation, 1984
- Long-term calcitonin therapy in postmenopausal osteoporosisMetabolism, 1984
- Salmon calcitonin therapy for paget's disease of bone the problem of acquired clinical resistanceArthritis & Rheumatism, 1980
- PAGET'S BONE DISEASE: RESPONSE TO HUMAN CALCITONIN IN PATIENTS RESISTANT TO SALMON CALCITONINThe Lancet, 1974